Published online before print January 24, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1
Departments of Clinical Biochemistry, Aarhus Hospital, and
* Medical Biochemistry, University of Aarhus, Denmark
1Correspondence: Department of Medical Biochemistry, University of Aarhus, Ole Worms Allé, Building 170, 8000 Aarhus C, Denmark. E-mail: skm{at}biokemi.au.dk
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Key Words: haptoglobin • haemoglobin • endocytic signal • transfection
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
CD163, which is expressed exclusively in monocytes/macrophages, is a relatively newly identified member of the macrophage scavenger receptor family (reviewed in ref. [2 ]). In addition to its function as a Hb scavenger, CD163 appears to be involved in intracellular signaling. This signaling function is triggered by ligand binding to CD163 at the cell surface and results in a protein tyrosine kinase-dependent signal and secretion of interleukin-6 (IL-6) and IL-10 [3 , 4 ]. The CD163-mediated IL-6 and IL-10 secretion points to an immunomodulatory function. Furthermore, as IL-6 and IL-10 are known to up-regulate CD163 (refs. [5 , 6 ] and reviewed in ref. [7 ]), these results suggest the existence of a positive feedback mechanism for CD163 induction. A role for CD163 in immunomodulation is also indicated by the finding that degradation of heme, internalized via CD163, results in the production of metabolites with suggested anti-inflammatory effects (reviewed in ref. [8 ]).
CD163 also exists as a soluble protein in normal human plasma, resulting from proteolytic shedding of the membrane-bound form [9 , 10 ]. Phorbol 12-myristate 13-acetate, lipopolysaccharide (LPS), and cross-linking of the Fc receptor for immunoglobulin G (IgG) have been reported to induce shedding of CD163 [11 12 13 ], but the biological function of soluble CD163 is not yet defined.
CD163 comprises a large, extracellular region with nine scavenger receptor cysteine-rich (SRCR) class B domains, a transmembrane segment, and a short cytoplasmic tail [14 ]. Several different CD163 mRNAs, all arising from alternative splicing of a single CD163 gene, have been described [14 , 15 ]. Three of these encode CD163 proteins with different C-terminal cytoplasmic tails: the CD163 short tail variant, previously demonstrated to mediate endocytosis of Hp-Hb [1 ], and two not-yet characterized forms (the CD163 long tail variant 1 and the CD163 long tail variant 2).
The cytoplasmic tails of these three CD163 isoforms share a common, 42 amino acid membrane proximal region, whereas the length and sequence of the extreme C-terminal region are specific for each variant. The membrane proximal region includes a potential internalization motif of the type YXX
(where represents a bulky hydrophobic residue), situated 24 residues downstream from the transmembrane segment (reviewed in refs. [16
, 17
]).
We recently characterized the ligand-binding properties of the extracellular region of CD163 and found that SRCR domain 3 of CD163 is critically involved in the binding of Hp-Hb [18 ]. In this study, the molecular characterization of CD163 concerns the endocytic properties of the intracellular region of the CD163 cytoplasmic isoforms stably expressed in Chinese hamster ovary (CHO) cells.
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
cDNA was synthesized by incubation of 1 µl RNA, 6.3 mM MgCl2, 0.3 mM deoxy-unspecified nucleoside 5'-triphosphate, 2.5 mM oligo dT primer, 20 U RNase inhibitor, and 50 U murine leukemia virus reverse transcriptase (RT) in a total volume of 20 µl (Applied Biosystems, Nærum, Denmark) at 42°C for 30 min, followed by 99°C for 5 min.
Real-time qPCR was performed for each splice variant in a LightCycler® system (Roche Diagnostics, Hvidovre, Denmark) by incubating 1 µl synthesized cDNA, 0.5 µl (5 pmol) of each primer (CD163 short tail variant forward primer: 5'-gtccaccaaattcaataccg-3', reverse primer: 5'-tcagaatggcctcctgagga-3'; CD163 long tail variant 1 forward primer: 5'-gtccaccaaattcaataccg-3', reverse primer: 5'-tccattccagaaataggaag-3'; CD163 long tail variant 2 forward primer: 5'-gtccaccaaattcaataccg-3', reverse primer: 5'-caaagtagaatgtctgtgcc-3'), 5 µl platinum CYBR Green qPCR SuperMix uracil DNA glycosylase (Roche Diagnostics), and 0.5 µl bovine serum albumin (BSA; 1 mg/ml) in a total volume of 10 µl (cycling conditions were 50°C for 2 min and 95°C for 2 min, followed by 50 cycles of 95°C for 5 s, 60°C for 10 s, and 72°C for 10 s). The PCR threshold cycle was determined by the LightCycler® software Version 3.5. A standard curve was included in each run by inclusion of a series of dilutions of RNA from specifically transfected cells. By RT-PCR analysis (using the primers 5'-acatagatcatgcatctgtcatttg-3' and 5'-cattctccttggaatctcacttcta-3', which amplify all three variants), the CD163-transfected cells were shown to contain similar amounts of the respective mRNA variants. The relative mRNA abundance of the three cytoplasmic CD163 variants in blood, liver, and spleen was then compared by normalizing to the measured level in the short tail variant.
Establishment of stable CD163 transfectant cells
cDNA encoding the three human cytoplasmic isoforms of CD163 [14
] was ligated into the KpnI and NotI sites of the mammalian expression vector pcDNA5/FRT (F1p recombination target) (Invitrogen). The CD163 short tail variant Y1091A mutant cDNA construct was generated by a two-step PCR using Pfu Turbo polymerase (Stratagene, La Jolla, CA). The first step produced a megaprimer using a mutated forward primer 5'-gtccaccaaattcaagcccgggagatgaattcttgcc-3' and reverse primer 5'-ccgctcgagtcagtgtggctcagaatggc-3', and the second step produced the total CD163 short tail variant Y1091A mutant cDNA using the megaprimer as reverse primer and the forward primer 5'-cccaagcttgaattcttagttgttttc-3'. In both reactions, the wild-type CD163 short tail variant cDNA was used as template. The CD163 short tail variant Y1091A mutant PCR product was purified with the QIAEX II gel extraction kit (Qiagen) and ligated into the XhoI and HindIII sites of the pcDNA5/FRT vector. The pcDNA5/FRT constructs were transfected into Flp-In CHO cells (Invitrogen) using FuGENE 6 (Roche Diagnostics). Stable transfectants were selected with 500–750 µg/ml Hygromycin B (Invitrogen), and expression products were analyzed by immunoblotting of cell lysates using a rabbit polyclonal anti-CD163 antibody [1
]. Stably transfected clones were grown in serum-free CHO medium (HyQ-CCM, HyClone, Logan, UT) containing 300 µg/ml Hygromycin B.
Binding of recombinant CD163 to cyanogen bromide (CNBr)-activated Sepharose 4B beads coupled with Hp-Hb
Hp (mixed phenotypes) and Hb A0 were from Sigma Chemical Co. CNBr-activated Sepharose 4B beads (Amersham Biosciences, Hillerød, Denmark) coupled with Hp-Hb were washed twice with a solution containing 2 mM CaCl2, 1 mM MgCl2, 10 mM Hepes, and 140 mM NaCl, pH 7.8, before incubation with cell lysates from CD163-transfected Flp-In CHO cells. After an overnight incubation at 4°C, beads were washed six times in the above solution. Bound CD163 was eluted by addition of sodium dodecyl sulfate (SDS)-containing sample buffer and visualized by Western blotting using the rabbit polyclonal anti-CD163 antibody.
Confocal immunofluorescence microscopy of CHO cells
We examined the cellular distribution of the CD163 variants in transfected Flp-In CHO cells by confocal immunofluorescent analysis. Cells were grown on chamber slides (Nunc, Roskilde, Denmark) or coverslips (Hounisen, Risskov, Denmark). For the surface-staining experiments, living cells were incubated in serum-free CHO medium containing 10 µg/ml rabbit polyclonal anti-CD163 antibody for 1 h at 4°C. After washing three times in phosphate-buffered saline (PBS) buffer (10 mM NaH2PO4, 0.15 M NaCl, 0.6 mM CaCl2), pH 7.4, the cells were fixed in 4% formaldehyde for 1 h at 4°C, washed three times in PBS, pH 7.4, containing 0.05% Triton X-100, followed by a 1-h incubation at room temperature with Alexa 488-conjugated secondary goat anti-rabbit IgG (Molecular Probes, Leiden, The Netherlands), diluted 1:200 in PBS buffer, pH 7.4, containing 0.05% Triton X-100.
To analyze the total cellular distribution of CD163 and to compare the CD163 localization with Vti1b/GS28 localization, fixed, permeabilized cells (fixed in 4% formaldehyde for 30 min at room temperature and washed three times in PBS buffer, pH 7.4, containing 0.05% Triton X-100) were incubated for 1 h at room temperature with rabbit polyclonal anti-CD163 antibody (10 µg/ml) and a mouse antibody against Vti1b or GS28 (both 1 µg/ml; Catalog No. 611434, BD Biosciences PharMingen, San Diego, CA) in PBS, pH 7.4, containing 0.05% Triton X-100. After washing three times in PBS, pH 7.4, with 0.05% Triton X-100, cells were incubated at room temperature for 1 h with the fluorescence-labeled secondary antibodies Alexa 488-conjugated goat anti-rabbit IgG and Alexa 594-conjugated goat anti-mouse IgG (Molecular Probes), both diluted 1:200 in PBS, pH 7.4, with 0.05% Triton X-100.
To visualize internalization of Hp-Hb, complexes of Hp(2-2) and Hb A0 (both from Sigma Chemical Co.) were labeled with Alexa fluor 488 (Molecular Probes). Cells were washed with PBS, pH 7.4, prior to incubation with Alexa-488-labeled Hp(2-2)-Hb [diluted in serum-free medium for CHO cells supplemented with 1% BSA, 100 µM chloroquine (Fluka, Buchs, Switzerland), and 100 µM leupeptin (Sigma Chemical Co.)] for 30 min at 37°C. At the end of the incubation period, the cells were washed in PBS, pH 7.4. Subsequently, 10 µg/ml rabbit polyclonal anti-CD163 (diluted in serum-free CHO medium) was added to the cells and allowed to bind CD163, exposed on the cell surface during a 1-h incubation period at 4°C. After washing in PBS, pH 7.4, the cells were fixed in 4% formaldehyde for 1 h at 4°C, followed by washing in PBS, pH 7.4, containing 0.05% Triton X-100, and incubation with Alexa-594-conjugated goat anti-rabbit IgG diluted 1:200 in PBS, pH 7.4, containing 0.05% Triton X-100 for 1 h at room temperature.
Immunostained cells were analyzed by confocal immunofluorescence microscopy using a Zeiss LSM-510 confocal microscope (Zeiss, Jena, Germany).
Endocytosis experiments
Endocytic analysis was performed with CD163-transfected or nontransfected Flp-In CHO cells grown to confluence in 24-well plates (0.07–0.09 mg protein/well) essentially as described [19
]. In brief, complexes of Hp(2-2) and Hb A0 (both from Sigma Chemical Co.) were labeled with 125I using the chloramine-T method, and triplicates of cells were incubated in serum-free CHO medium containing 4000 counts per minute 125I-labeled Hp(2-2)-Hb for various time intervals at 37°C. At the end of the incubation period, the medium was removed and precipitated with 12.5% trichloroacetic acid (TCA) to separate soluble fragments of degraded Hp(2-2)-Hb from intact Hp(2-2)-Hb. Degradation of ligand was determined as the cell-mediated increase in TCA-soluble radioactivity in the medium. Finally, the washed cell layers were lysed with 0.5 M NaOH, and cell-associated radioactivity was determined by counting the radioactivity of the lysate.
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
 View larger version (21K): [in a new window] |
Figure 1. Schematic presentation of the CD163 cytoplasmic tail variants. SRCR domains are indicated by oval symbols. The variants have amino acids (aa.) 1–1109 in common. This part encodes the extracellular domain, the transmembrane region, and the first 42 amino acids of the cytoplasmic tail. The amino acid sequences of the different C-terminal tails are displayed. Numbers denote amino acid positions.
|
50% of the total mRNA amount of CD163 cytoplasmic variants; see Fig. 2A
) as well as in liver and spleen (accounting for 70% of the total mRNA amount of CD163 cytoplasmic variants in both tissues; see Fig. 2C
and D
). The CD163 long tail variant 1 was the least abundant mRNA species in blood, whereas in liver and spleen, the least abundant variant was the CD163 long tail variant 2. We also investigated the CD163 mRNA expression profile in mononuclear cells and found the relative abundance of the variants to be similar to that in blood (Fig. 2B)
.
 View larger version (37K): [in a new window] |
Figure 2. mRNA expression of CD163 cytoplasmic tail variants in human blood and tissues. The relative abundance of the CD163 short tail variant, the CD163 long tail variant 1, and the CD163 long tail variant 2 was determined by qPCR in blood (A), mononuclear cells with (+) or without (–) stimulation with dexamethasone (B), liver (C), and spleen (D). RNA from Flp-In CHO cells stably transfected with each variant was used as calibrators in qPCR reactions, and results were normalized to the short tail variant (=1).
|
1.7-fold up-regulation).
The cytoplasmic tail variants of CD163 bind Hp-Hb
To analyze functional properties of the CD163 cytoplasmic tail isoforms, we established stably transfected Flp-In CHO cell lines expressing the three variants (Fig. 3A
). The Flp-In system, which allows the CD163 cDNAs to be inserted at the same site in the genome, was chosen to avoid substantial differences in transcriptional activity. Even so, protein expression of the CD163 short tail variant was 50% of the CD163 long tail variant 1 expression and 200% of the CD163 long tail variant 2 expression, as determined by Western blot analysis, thus suggesting that the tail sequences affect the overall expression levels.
 View larger version (37K): [in a new window] |
Figure 3. Expression of recombinant CD163 cytoplasmic tail variants in Flp-In CHO cells. (A) Detection of recombinant CD163 splice variants in lysates of stably transfected Flp-In CHO cells. Triton X-100 solubilized cells were subjected to nonreducing SDS-polyacrylamide gel electrophoresis (4–16% polyacrylamide) followed by electroblotting and immunodetection with rabbit polyclonal anti-CD163 antibody. Positions of molecular size standard markers are indicated. The protein expression of the CD163 short tail variant was 50% of the CD163 long tail variant 1 expression and 200% of the CD163 long tail variant 2 expression. (B) Hp-Hb binding ability of the expressed CD163 variants. Cell lysates were incubated with Hp-Hb-sepharose beads or blank sepharose beads. After extensive washing, bound material was eluted and subjected to immunoblotting as described in A.
|
Transfected cells expressing the CD163 short tail variant have a higher capacity for ligand internalization and degradation than transfected cells expressing the CD163 long tail variants 1 and 2
To compare the endocytic properties of the CD163 variants, Flp-In CHO cells transfected with the three cytoplasmic tail isoforms of CD163 were incubated with 125I-labeled Hp-Hb. Figure 4A
shows the time course of cell-associated radioactivity and TCA-soluble radioactivity (representing degraded Hp-Hb) in the medium. As previously seen [1
], the cell-associated radioactivity in cells expressing the CD163 short tail variant reached a plateau after 1 h of incubation (left panel). A similar time course of cell-associated radioactivity was observed for cells expressing the CD163 long tail variants 1 or 2, although the plateau reached in the cells expressing the CD163 long tail variant 1 was at a lower level (Fig. 4A
, middle panels).
 View larger version (45K): [in a new window] |
Figure 4. Effect of the cytoplasmic tails on Hp-Hb endocytosis in stably transfected Flp-In CHO cells. (A) Time course for cell-associated ( ) and degraded ( ) 125I-Hp-Hb in CD163-transfected or nontransfected Flp-In CHO cells. Confluent cell layers (0.07–0.09 mg protein/well) were incubated with 125I-Hp-Hb at 37°C for various time intervals. Degradation was measured as the cell-mediated increase of TCA-soluble radioactivity in the growth medium, and cell-associated ligand was determined by counting the radioactivity of cell lysate. Values are mean ± 1 SD of triplicate samples. The experiments shown are representative of three independently performed experiments. As a result of the different expression levels of the CD163 variants (see Fig. 3A
), the values measured in cells expressing the CD163 long tail variants 1 and 2 were standardized to the values of the CD163 short tail variant-expressing cells by multiplication, by 0.5 and 2, respectively. (B) Effect of the lysosomal inhibitors chloroquine and leupeptin (both 100 µM) on Hp-Hb endocytosis. The amount of cell-associated (open bars) and degraded (solid bars) 125I-Hp-Hb in the absence or presence of chloroquine and leupeptin after a 4-h incubation period at 37°C is indicated. Values are mean ± 1 SD of triplicate samples. The experiments shown are representative of three independently performed experiments.
|
2.5-fold and 1.6-fold higher than in cells expressing the CD163 long tail variants 1 and 2, respectively. Only a low degree of cell-associated radioactivity and TCA-soluble radioactivity was detected in nontransfected Flp-In CHO cells (Fig. 4A
, right panel). The lysosomal inhibitors leupeptin and chloroquine (both 100 µM) strongly inhibited degradation of the 125I-Hp-Hb complex in all three transfected cell lines (Fig. 4B) , and accordingly, the amount of cell-associated radioactivity was increased. We conclude from this set of experiments that the CD163 cytoplasmic tail isoforms are all able to mediate endocytosis of the Hp-Hb complex and that cellular uptake is accompanied by lysosomal degradation of the cargo. However, in relation to the overall CD163 protein expression level, the CD163 short tail variant has a substantially higher endocytic efficacy than the CD163 long tail variants 1 and 2.
Cellular distribution of the CD163 cytoplasmic tail variants
To further characterize the CD163 cytoplasmic tail variants, we investigated their subcellular distribution in transfected Flp-In CHO cells by confocal immunofluorescence microscopy. Analysis of CD163 cell-surface expression disclosed important differences among the cell lines expressing the three CD163 variants. As seen in Figure 5
and confirmed by semiquantitative assessment of the fluorescence intensity by use of the LSM-510 software, cells transfected with the CD163 short tail variant exhibited a pronounced cell-surface staining (left panel), whereas cells expressing the CD163 long tail variants 1 or 2 displayed a significantly lower degree of cell-surface staining (Fig. 5
, middle and right panels). The surface staining of the CD163 variants was not affected by incubation with a saturating concentration (1 µM) of the ligand Hp-Hb (data not shown). This suggests a constitutive recycling of the CD163 variants to the plasma membrane.
 View larger version (12K): [in a new window] |
Figure 5. Cell-surface immunostaining of CD163 cytoplasmic tail variants in transfected Flp-In CHO cells. Detection of CD163 at the cell surface by confocal immunofluorescence microscopy. Living cells were incubated with rabbit polyclonal anti-CD163 antibody at 4°C. After fixation, CD163 was visualized using Alexa-488-labeled goat anti-rabbit antibody.
|
 View larger version (53K): [in a new window] |
Figure 6. Subcellular distribution of CD163 cytoplasmic tail variants in transfected Flp-In CHO cells. Detection of CD163 in stably transfected Flp-In CHO cells by confocal immunofluorescence microscopy. Fixed and permeabilized cells were incubated with rabbit polyclonal anti-CD163 antibody and mouse antibodies against Vti1b or GS28. CD163 variants were visualized using Alexa-488-labeled goat anti-rabbit antibody (green). Vti1b/GS28 was visualized with Alexa-594-labeled goat anti-mouse antibody (red).
|
 View larger version (28K): [in a new window] |
Figure 7. Inhibition of Hp-Hb endocytosis by mutation of the candidate internalization signal 1091YREM1094. (A) Sequence of the cytoplasmic tail of the CD163 short tail variant. The potential internalization signal is highlighted in green. The position of the introduced mutation is indicated. (B) Cell-associated (open bars) and degraded (solid bars) 125I-Hp-Hb in Flp-In CHO cells expressing the CD163 short tail variant wild-type receptor or the CD163 short tail variant Y1091A mutant form. Cells were incubated with 125I-Hp-Hb at 37°C, and the amount of cell-associated and degraded 125I-Hp-Hb after 4 h was determined as described in Figure 4
. Values are mean ± 1 SD of triplicate samples. The experiments are representative of three independent experiments. (C) Vesicular uptake of fluorescent Hp-Hb complexes (green) in transfected Flp-In CHO cells and cell-surface immunostaining of CD163 (red). Cells were incubated with Alexa-488-labeled Hp-Hb for 30 min at 37°C in the presence of the lysosomal inhibitors chloroquine and leupeptin (both 100 µM), followed by incubation with rabbit polyclonal anti-CD163 antibody at 4°C. After fixation, cells were incubated with Alexa-594-labeled goat anti-rabbit antibody to visualize CD163 at the cell surface. Notice the low accumulation of Alexa-488-labeled Hp-Hb in the cells expressing the receptor mutant.
|
2.5-fold lower than in cells expressing the wild-type receptor. To evaluate the effect of the mutation at the single-cell level, the endocytic properties were also investigated by confocal immunofluorescence microscopic analysis after incubation with fluorescent Hp-Hb complexes (Fig. 7C)
. Although the cell lines showed a similar level of surface staining (data not shown), the vesicular uptake of fluorescent Hp-Hb was reduced greatly in cells expressing the CD163 short tail variant Y1091A mutant compared with cells expressing the wild-type receptor. |
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
We furthermore investigated the mRNA expression profile of the CD163 cytoplasmic tail isoforms and found that all three variants are expressed in blood, liver, and spleen. It is important that our results demonstrate that the CD163 short tail variant is the predominant mRNA species in blood and both tissues examined. Previous work on CD163 splice variant expression is restricted to studies on the CD163-expressing SU-DHL-1 cell line and human monocytes (LPS-stimulated, glucocorticoid-stimulated, or nonstimulated) [14 , 20 ]. In these studies, the CD163 short tail variant mRNA was also shown to represent the major CD163 mRNA species.
The ability of the three CD163 variants to mediate internalization of surface-bound ligand appears to be a result of a YXX internalization motif [26
] present in the common part of the cytoplasmic tail region. Accordingly, substitution of the Tyr residue of the 1091YREM1094 motif in the CD163 short tail variant strongly impaired endocytosis. The low endocytic activity of the CD163 long tail variants relative to the CD163 short tail variant is therefore more likely to be a consequence of differences in cell-surface expression level than differences in endogenous endocytic potential.
It is interesting that alternative splicing of cytoplasmic domains as a means of modulating receptor subcellular distribution has also been reported for the human SorCs1 receptor and several members of the integrin family (ref. [27 ] and reviewed in ref. [28 ]). The fact that the bulk of the CD163 long tail variants concentrates on TGN/endosomal compartments at steady-state in transfected cells suggests alternative functions for these variants. One possible function for CD163 in the TGN is sorting of proteins transported via the secretory pathway. However, it is also feasible that the large pool of CD163 in the TGN area serves as a temporary storage, which can be released and transported to the cell surface in response to specific stimuli.
Of the three variants studied, the CD163 long tail variant 1 was particularly enriched inside the cell, where it displayed complete colocalization with Vti1b. It is intriguing that an acidic region containing a candidate casein kinase II (CKII) phosphorylation site is found in the cytoplasmic tail of the CD163 long tail variant 1 but is absent in the other tail variants (Fig. 8 ). AC motifs containing CKII phosphorylation sites are found in several transmembrane proteins, including the endoprotease furin, which localize to the TGN at steady-state (reviewed in ref. [26 ]). Upon budding from the TGN, furin can be retrieved from a post-TGN endosome to the TGN by a mechanism dependent on CKII phosphorylation of the AC motif [29 30 31 ]. By analogy with this, it is tempting to believe that the AC motif residing in the CD163 long tail variant 1 serves as a TGN-retrieval signal that mediates high accumulation of the CD163 long tail variant 1 in the endosomal/TGN compartment.
 View larger version (22K): [in a new window] |
Figure 8. Multiple species alignment of the CD163 cytoplasmic domains. Alignment of the cytoplasmic tail of human CD163 cytoplasmic tail variants (short tail variant, GenBank Accession No. Z22968; long tail variant 1, GenBank Accession No. Z22969; long tail variant 2, GenBank Accession No. Z22970) and the cytoplasmic region of pig CD163 (GenBank Accession No. NM_213976), rat CD163 (GenBank Accession No. XM_232342), chimpanzee CD163 (GenBank Accession No. XM_508986), dog CD163 (GenBank Accession No. XM_534898), mouse CD163 (GenBank Accession No. AF274883), and cow CD163 (GenBank Accession No. XM_613380). Please note that only an incomplete version of the cow CD163 sequence (lacking the most C-terminal residues) is available. The acidic cluster (AC) of human CD163 long tail variant 1 is indicated by a horizontal line. Putative CKII and protein kinase C (PKC) phosphorylation motifs in the three human variants are shown.
|
Sequence alignments of human CD163 with mouse CD163 reveals yet an interesting feature of the CD163 long tail variant 1 tail sequence. Whereas the 39 most N-terminal residues of the mouse CD163 cytoplasmic domain show considerable homology with the common cytoplasmic region of the human CD163 cytoplasmic tail variants, including a potential internalization signal of the YXX type (Fig. 8)
, the remaining part of the mouse CD163 C-terminal sequence displays high homology to the extreme C terminus of the CD163 long tail variant 1 (Fig. 8)
. No corresponding region is found in the tails of the CD163 short tail variant or the CD163 long tail variant 2. The available dog CD163 sequence also reveals overall high homology to the human CD163 long tail variant 1 sequence. However, in this case, the homology stems from the 25 residues immediately following the membrane proximal region of the long tail variant 1 in addition to the membrane proximal region itself. It is intriguing that the part corresponding to the extreme C-terminal of the human CD163 long tail variant 1 and the mouse CD163 lacks in the dog protein. Analysis of the available CD163 sequence from chimpanzee reveals almost complete sequence identity between the chimpanzee CD163 cytoplasmic domain and the entire cytoplasmic domain of the human CD163 long tail variant 1.
Available species-specific CD163 sequences also include the pig, rat, and cow CD163 sequences. Whereas the pig and rat sequences most closely resemble the human CD163 short tail variant sequence, the cow CD163 is more related to the human CD163 long tail variant 2 (Fig. 8) . The finding that close homologues of all three human CD163 cytoplasmic tail isoforms are found in various species underscores the physiological relevance of the human CD163 cytoplasmic tail variants.
The common cytoplasmic domain sequence of the human CD163 variants encompasses motifs complying with the consensus for phosphorylation by PKC and CKII (Fig. 8)
. Accordingly, all three variants are phosphorylated by PKC-
in vitro, whereas only the CD163 short tail variant and the CD163 long tail variant 1 are phosphorylated by CKII in vitro [33
]. As described previously [33
], the cytoplasmic domain sequence specific for the CD163 long tail variant 1 contains additional, potential phosphorylation sites for PKC and CKII (Fig. 8)
, thus suggesting that the CD163 long tail variant 1 could be subject to a higher degree of phosphorylation than its tail variants. Alternative splicing of the CD163 cytoplasmic region may therefore modulate the phosphorylation status of the intracellular tail and possibly, intracellular signaling mediated by CD163, as has been reported for the homologous SRCR-containing protein CD6 [34
]. In this way, CD163 might contribute to immunological functions of the macrophage [35
]. However, this aspect of the CD163 variants remains to be investigated further.
In conclusion, the present study shows that despite a common signal conveying endocytosis, the CD163 cytoplasmic tail variants display divergent endocytic activities as a result of differences in their subcellular localization patterns. The high endocytic efficacy of the CD163 short tail variant, together with its relatively high mRNA expression level, suggests it to be the main contributor to Hp-Hb uptake from the circulation. The high content of the long tail variants in the Golgi area indicates that these variants represent an intracellular CD163 pool for mobilization and/or a pool with specific intracellular functions.
Received October 24, 2005; accepted November 17, 2005.
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
R triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163 J. Leukoc. Biol. 76,271-277 plus glucocorticoids stimulate the expression of a newly identified human mononuclear phagocyte-specific antigen J. Immunol. 140,2296-2304[Abstract]This article has been cited by other articles:
 |
|
 |
|
  H. Van Gorp, W. Van Breedam, P. L. Delputte, and H. J. Nauwynck Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus J. Gen. Virol., December 1, 2008; 89(12): 2943 - 2953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Calvert, D. E. Slade, S. L. Shields, R. Jolie, R. M. Mannan, R. G. Ankenbauer, and S.-K. W. Welch CD163 Expression Confers Susceptibility to Porcine Reproductive and Respiratory Syndrome Viruses J. Virol., July 15, 2007; 81(14): 7371 - 7379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. O. Fabriek, M. M. J. Polfliet, R. P. M. Vloet, R. C. van der Schors, A. J. M. Ligtenberg, L. K. Weaver, C. Geest, K. Matsuno, S. K. Moestrup, C. D. Dijkstra, et al. The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor Blood, June 15, 2007; 109(12): 5223 - 5229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Schaer, G. Schoedon, A. Imhof, M. O. Kurrer, and D. J. Schaer Constitutive Endocytosis of CD163 Mediates Hemoglobin-Heme Uptake and Determines the Noninflammatory and Protective Transcriptional Response of Macrophages to Hemoglobin Circ. Res., October 27, 2006; 99(9): 943 - 950. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
